BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Clofibrate
,
rs2300478
,
PBX1
,
T cell differentiation
,
Ischemia
,
Stem cell
,
Biofuel
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
PD-%201
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for PD-%201
Explore Curated Studies Results
Literature
Most Relevant Literature
Mutation analysis of common deafness genes among 1,201 patients with non-syndromic hearing loss in S…
Measuring Dysfunctional Grief due to a COVID-19 Loss: A Kurdish Validation Study of the Pandemic Gri…
Early Postoperative Treatment versus Initial Observation in CNS WHO Grade 2 and 3 Oligodendroglioma:…
Discovery of New Protein Targets of BPA Analogs and Derivatives Associated with Noncommunicable Dise…
Baseline mutations and ctDNA dynamics as prognostic and predictive factors in ER-positive/HER2-negat…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
PK and PD Study of LUM-201 in Children With Idiopathic Growth Hormone Deficiency: (OraGrowtH212)
Study of NEO-201 in Solid Tumors Expansion Cohorts
A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer
Safety and Tolerability of TWP-201 in Healthy Female Subjects
Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-201 in Subjects Ages 16-35 …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ